Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Pet Pharm Biotech CoROCO:7762 +0.20%19 Days Inventory is 34.31 as of Dec. 2025, which is 38% below its 10-year median of 55.04. GuruFocus rates ROCO:7762 with a GF Score™ of 19/100. The stock has 5 warning signs investors should review. Among 921 Drug Manufacturers companies, Pet Pharm Biotech Co ranks better than 95.77% on this metric.
The historical rank and industry rank for Pet Pharm Biotech Co's Days Inventory or its related term are showing as below:
ROCO:7762'
s Days Inventory Range Over the Past 10 Years
Min: 43.28 Med: 55.04 Max: 73.56
Current: 43.28
During the past 4 years, Pet Pharm Biotech Co's highest Days Inventory was 73.56. The lowest was 43.28. And the median was 55.04.
ROCO:7762's Days Inventory is ranked better than 95.77% of 921
companies
in the Drug Manufacturers industry
Industry Median: 164.48
vs ROCO:7762: 43.28
Pet Pharm Biotech Co's Days Inventory
declined
from Dec. 2024 (60.72) to Dec. 2025 (34.31).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Pet Pharm Biotech Co's Inventory Turnover for the
six
months ended in Dec. 2025 was 5.32.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Pet Pharm Biotech Co's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 0.09.
Pet Pharm Biotech Co (ROCO:7762) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Pet Pharm Biotech Co's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Pet Pharm Biotech Co's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Pet Pharm Biotech Co Days Inventory Related Terms
Pet Pharm Biotech Co Days Inventory Historical Data
* Premium members only.
The historical data trend for Pet Pharm Biotech Co's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:7762 vs LLY, JNJ, ABBV: Days Inventory Comparison
For the Drug Manufacturers - General subindustry, Pet Pharm Biotech Co's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pet Pharm Biotech Co Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Pet Pharm Biotech Co's Days Inventory distribution charts can be found below:
* The bar in red indicates where Pet Pharm Biotech Co's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pet Pharm Biotech Co (ROCO:7762) has a Days Inventory of 34.31 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Pet Pharm Biotech Co and its competitors. This is 38% below median its historical median of 55.04. Over the past decade, Pet Pharm Biotech Co's Days Inventory has ranged from 43.28 to 73.56. According to the industry distribution chart, Pet Pharm Biotech Co ranks #39 out of 921 companies in the Drug Manufacturers industry, placing it in the top 4.2%.
Is Pet Pharm Biotech Co's Days Inventory too high?
Pet Pharm Biotech Co's current Days Inventory of 34.31 is 38% below median its 10-year median of 55.04. Over the past 10 years, this metric has ranged from a low of 43.28 to a high of 73.56. The Drug Manufacturers industry median Days Inventory is 164.48. Pet Pharm Biotech Co's value of 34.31 is 79.1% below this industry median. Based on the distribution chart, Pet Pharm Biotech Co ranks #39 out of 921 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Pet Pharm Biotech Co has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Pet Pharm Biotech Co's Days Inventory compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Pet Pharm Biotech Co ranks #39 out of 921 companies for Days Inventory. This places Pet Pharm Biotech Co in the top 4% of its industry — outperforming the majority of peers. The industry median Days Inventory is 164.48. Pet Pharm Biotech Co's value of 34.31 is 79.1% below this benchmark. Historically, Pet Pharm Biotech Co's own Days Inventory has ranged from 43.28 to 73.56 over the past decade. While the company's 10-year median is 55.04 vs. the industry median of 164.48, Pet Pharm Biotech Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.48, based on 921 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pet Pharm Biotech Co's current Days Inventory of 34.31 is 79.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Pet Pharm Biotech Co and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pet Pharm Biotech Co's current Days Inventory is 34.31, which is 38% below median its own 10-year median of 55.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pet Pharm Biotech Co stock overvalued right now?
Pet Pharm Biotech Co (ROCO:7762) has a current Days Inventory of 34.31. The current Days Inventory is 34.31, which is 38% below median its 10-year median of 55.04 and 79.1% below the Drug Manufacturers industry median of 164.48. Pet Pharm Biotech Co's overall GF Score™ is 19/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Pet Pharm Biotech Co (ROCO:7762), the current Days Inventory is 34.31 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Pet Pharm Biotech Co Ltd is a Pharmaceutical company. The company is engaged in manufacturing medicinal products and medicine drugs. The products offered by the company include FDG Fluodeoxyglucose Injection (18F-FDG), Naolixi Injection (18F-FBB), Sodium fluoride injection (18F-NaF), and others.
19GF Score
Get the complete analysis for ROCO:7762
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:7762 has been successfully added to your 
